Cytokine Market Size

Cytokine Market size was valued at USD 88.57 billion in 2024 and is expected to exceed USD 229.53 billion by the end of 2037, expanding at over 7.6% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of cytokine is evaluated at USD 93.96 billion.

The growth of the market is expected to be driven by an increased incidence of cancer worldwide over the forecast period. Immunotherapies using cytokine, which are capable of regulating the immune host response to cancer cells as well as inducing tumor cell death, have been an emerging field for cancer treatment. Cancer could be a driving cause of death around the world, accounting for about 10 million deaths in 2020, or about one in six passings. The foremost common cancers are breast, lung, colon rectum, and prostate cancers.

The complex arrangement of development variables and cytokine help all tissues and organs' cellular separation and recovery. As a result, cytokine are thought to be greatly imperative in stem cell treatment. It is expected that utilizing stem cells in regenerative pharmaceuticals and specific cytokine and development components will hold noteworthy guarantees for treating numerous human illnesses. For illustration, the Boston Stem Cell Center has given stem cell treatments by combining particular cytokine, development variables, and interleukins to intercede with musculoskeletal repair. This helps in programming the repair to prepare and fitting it to the sort of sue in musculoskeletal conditions and wounds.